Expression of IGF-I, IGF-I receptor and IGF binding proteins -1, -2, -3, -4 and -5 in human atherectomy specimens

Regulatory Peptides

Volumn 67, Issue 3, 1996, Pages 137-144

  Grant, M B ^a   Wargovich, T J ^a   Ellis, E A ^a   Tarnuzzer, R ^a   Caballero, S ^a   Estes, K ^b   Rossing, M ^a   Spoerri, P E ^a   Pepine, C ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

atherectomy; IGF binding protein; IGF I receptor; immunocytochemistry; quantitative RT PCR; smooth muscle cell

Indexed keywords

SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; ARTICLE; ATHERECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTENOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER;

ATHERECTOMY, CORONARY; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; ELECTROPHORESIS, AGAR GEL; GENE EXPRESSION REGULATION; GOLD COLLOID; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MICROSCOPY, IMMUNOELECTRON; POLYMERASE CHAIN REACTION; RECEPTOR, IGF TYPE 1; RNA, MESSENGER;

ANGINA;

EID: 0030591838     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(96)00124-3     Document Type: Article

References (38)

1. Austin G., Ratliff N., Hollman J., Tabei S., Phillips D. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J. Am. Coll. Cardiol. 6:1985;369-375.
2. Ohara T., Kodama K., Mishima M., Nanto S., Harayama A., Yutani C. Ultrastructural findings of proliferating and migrating smooth muscle cells at the site of percutaneous transluminal coronary angioplasty. J. Am. Coll. Cardiol. 11:1988;131A.
3. Bobik A., Campbell J.H. Vascular derived growth factors: cell biology, pathophysiology, and pharmacology. Pharmacol. Rev. 45:1993;1-42.
4. Klagsbrun M., Edelman E.R. Biological and biochemical properties of fibroblast growth factors. Implications for the pathogenesis of atherosclerosis. Arteriosclerosis. 9:1989;269-278.
5. Nikol S., Isner J.M., Pickering J.G., Kearney M., Leclerc G., Weir L. Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. J. Clin. Invest. 90:1992;1582-1592.
6. Libby P., Schwartz D., Brogi E., Tanaka H., Clinton K. A cascade model for restenosis: a special case of atherosclerosis progression. Circulation. 86((Suppl. III)):1992;III47-III52.
7. Grant M.B., Wargovich T.J., Ellis E.A., Caballero S., Mansour M., Pepine C.J. Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells: a potential treatment for restenosis. Circulation. 89:1994;1511-1517.
8. Banskota N.K., Taub R., Zellner K., King G.L. Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells, Mol. Endocrinol. 3:1989;1183-1190.
9. Karey K.P., Marquardt H., Sirbasku D.A. Human platelet-derived mitogens, I. Identification of insulin-like growth factors I and II by purification and N alpha amino acid sequence analysis. Blood. 74:1989;1084-1092.
10. Cercek B., Fishbein M.C., Forrester J.S., Helfant R.H., Fagin J.A. Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ. Res. 66:1990;1755-1760.
11. Clemmons D.R. IGF binding proteins: regulation of cellular actions. Growth Regul. 2:1992;80-87.
12. Neely E.K., Beukers W.M., Oh Y., Cohen P., Rosenfeld R.G. Insulin-like growth factor receptors. Acta Pediatr. Scand. 372((Suppl.)):1991;116-123.
13. Elgin R.G., Bushby W.J.J., Clemmons D.R. An insulin-like growth factor OIGF) binding protein enhances the biological response to IGF-I. Proc. Natl. Acad. Sci. USA. 84:1987;3254-3258.
14. Sara V.R., Hall K. Insulin-like growth factors and their binding proteins. Physiol. Rev. 70:1990;591-614.
15. Clemmons D.R., Gardner L.I. A factor contained in plasma is required for IGF binding protein-1 to potentiate the effect of IGF-I on smooth muscle cell DNA synthesis. J. Cell Physiol. 145:1990;129-139.
16. Ross M.G., Szabo L.F., Wallace J.C., Ballard F.J. Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-I and IGF-II but not des-(1-3)-IGF-I. Biochem. J. 258:1989;267-272.
17. Sambrook, J., Fitch, E.F. and Maniatis, R., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
18. Tarnuzzer R.W., Macauley S.P., Farmerie W.G., Caballero S., Ghassemifar M.R., Anderson J.T., Robinson C.P., Grant M.B., Humphreys-Beher M.G., Frazen L., Peck A.B., Schultz G.S. Competitive RNA templates for detection and quantitation of growth factors, cytokines, extracellular matrix components and matrix metalloproteinases by RT-PCR. Biotechniques. 20:1996;670-674.
19. Delafontaine P., Lou H., Alexander R.W. Regulation of insulin-like growth factor I messenger RNA levels in vascular smooth muscle cells. Hypertension. 18:1991;742-747.
20. Clemmons D.R. Interaction of circulating cell-derived and plasma growth factors in stimulating cultured smooth muscle cell replication. J. Cell Physiol. 121:1984;425-430.
21. Ross R., Masuda J., Raines E.W. Cellular interactions, growth factors, and smooth muscle proliferation in atherogenesis. Ann. N.Y. Acad. Sci. 598:1990;102-112.
22. Hwang D.L., Latus L.J., Lev-Ran A. Effects of platelet-contained growth factors (PDGF, EGF, IGF-I, and TGF-beta) on DNA synthesis in porcine aortic smooth muscle cells in culture. Exp. Cell Res. 200:1992;358-360.
23. Hansson H.A., Brandsten C., Lossing C., Petruson K. Transient expression of insulin-like growth factor I immunoreactivity by vascular cells during angiogenesis. Exp. Mol. Pathol. 50:1989;125-138.
24. Rechler, M.M. and Nissley, S.P., Insulin-like growth factors. In M.B. Sporn and A.B. Roberts, (Eds.), Peptide Growth Factors and Their Receptors, Springer, Berlin, 1990, p. 263.
25. Polanco J.I., Berciano M.T., Lafarga M., Javier L., Pocovi M., Rodriguez-Rey I. Expression of insulin-like growth factor MRNA in rabbit atherosclerotic lesions. Biochem. Biophys. Res. Commun. 209:1995;182-190.
26. Stiles C.D., Capone G.T., Scher C.D., Antoniades H.N., Van Wyk J.J., Pledger W.J. Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc. Natl. Acad. Sci. USA. 76:1979;1279-1283.
27. Bourner M.J., Busby W. Jr., Siegel N.R., Krivi G.G., McCusker R.H., Clemmons D.R. Cloning and sequence determination of bovine insulin-like growth factor binding protein-2 (IGFBP-2): comparison of its structural and functional properties with IGFBP-1. J. Cell Biochem. 48:1992;215-226.
28. Parker A., Gockerman A., Busby W.H., Clemmons D.R. Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells. Endocrinology. 136:1995;2470-2475.
29. Kuntz R.E., Gibson C.M., Nobuyoshi M., Baim D.S. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J. Am. Coll. Cardiol. 21:1993;15-25.
30. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16:1995;3-34.
31. Hossenlopp P., Segovia B., Lassare C., Roghani M., Gredon M., Binoux M. Evidence of enzymatic degradation of insulin-like growth factor binding protein in 150k complex during pregnancy. J. Clin. Endocrinol. Metab. 71:1990;797-805.
32. Gockerman A., Clemmons D.R. Porcine aortic smooth muscle cells secrete a serine protease for insulin-like growth factor binding protein-2. Circ. Res. 76:1995;514-521.
33. Kamyar A., Pirola C.J., Wang H.M., Sharifi B., Mohan S., Forrester J.S., Fagin J.A. Expression and insulin-like growth factor-dependent proteolysis of insulin-like growth factor-binding protein-4 are regulated by cell confluence in vascular smooth muscle cells. Circ. Res. 74:1994;576-586.
34. Clemmons D.R., Elgin R.G., Han V.K., Casella S.J., D'Ercole A.J., Van Wyk J.J. Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulin-like growth factor I. J. Clin. Invest. 77:1986;1548-1556.
35. DeVroede M.A., Tseng L.Y., Katsoyannis P.G., Nissley S.P., Rechler M.M. Modulation of insulin-like growth factor I binding to human fibroblast monolayer cultures by insulin-like growth factor carrier proteins released to the incubation media. J. Clin. Invest. 77:1986;602-613.
36. Andress D.L., Birbaum R.S. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J. Biol. Chem. 267:1992;22467-22472.
37. Jones J.I., Gockerman A., Busby W.H., Chamacho-Habner C., Clemmons D.R. Extracellular matrix contains insulin-like growth factor binding protein-5; potentiation of the effects of IGF-I. J. Cell Biol. 121:1992;679-687.
38. Spoerri P.E., Ellis E.A., Tarnuzzer R.W., Grant M.B. IGF-I, IGF-I receptor and IGF binding proteins in human retinal endothelial cell culture from diabetic and non diabetic donors. Invest. Ophthalmol. 37:1996;S203.